Disseminated coccidioidomycosis in an immunocompetent person living in New York City.

J Urban Health

Department of Emergency Medicine, Bellevue Hospital Center, New York, NY 10016, USA.

Published: June 2005

Coccidioidomycosis is a disease caused by Coccidioides immitis, a soil-inhabiting fungus endemic to the desert climate of the southwestern United States and Central and South America. We report a case of disseminated coccidioidomycosis in a previously healthy person living in New York City, who was initially thought to have tuberculosis. The incidence of coccidioidomycosis has been increasing in both endemic and nonendemic areas, but diagnosis is often delayed or missed in nonendemic areas, resulting in extensive and unnecessary medical workup for other diseases or progression to serious disease. Therefore, clinicians should increase their awareness and consideration of this disease in patients with chronic systemic illness.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3456575PMC
http://dx.doi.org/10.1093/jurban/jti057DOI Listing

Publication Analysis

Top Keywords

disseminated coccidioidomycosis
8
person living
8
living york
8
york city
8
nonendemic areas
8
coccidioidomycosis immunocompetent
4
immunocompetent person
4
city coccidioidomycosis
4
coccidioidomycosis disease
4
disease caused
4

Similar Publications

Article Synopsis
  • A 35-year-old male presented with back pain and masses on his arms, having a previous sacral lesion suspected to be a fungal infection that was never fully investigated.
  • CT and MRI showed destructive bone lesions indicating a possible disseminated infection, and biopsies confirmed the presence of Blastomyces dermatitidis.
  • Despite initial concerns about his condition, the patient had no neurological deficits and showed improvement with medical treatment, highlighting the importance of clinical evaluation in making surgical decisions for spinal fungal infections.
View Article and Find Full Text PDF

Updates in Coccidioidomycosis.

Infect Dis Clin North Am

December 2024

Department of Internal Medicine, Division of Infectious Diseases, University of California Davis Medical Center, Sacramento, CA, USA; Department of Medical Microbiology and Immunology, University of California, Davis, CA, USA; UC-Davis Center for Valley Fever. Electronic address:

Coccidioidomycosis is the clinical disease caused by the dimorphic pathogenic fungi Coccidioides immitis and C posadasii. The number of clinically recognized coccidioidomycosis cases continues to increase yearly including in regions outside the traditional regions of endemicity. Following inhalation of Coccidioides spores, the course may range from asymptomatic exposure with resultant immunity, to a subacute pulmonary illness, to life-threatening disseminated infection.

View Article and Find Full Text PDF

Background: Coccidioidomycosis (Valley Fever) is a dimorphic fungal infection endemic to the southwest United States, Mexico, Central and South America, which can lead to chronic debilitating illness and death.

Objectives: This qualitative study was conducted to develop a bespoke patient-reported outcome measure for patients with chronic disseminated coccidioidomycosis to assess health-related quality of life (HRQoL) impacts.

Patients And Methods: Online, first-person narratives of patient experiences of disseminated coccidioidomycosis were used to create a patient-centred conceptual model of symptoms and impacts of the condition.

View Article and Find Full Text PDF

How I Do It: Managing Cavitary Coccidioidomycosis Expert Opinions for Improving Patient Outcomes.

Chest

December 2024

Division of Infectious Diseases, Department of Medicine, Mayo Clinic Arizona, Phoenix, AZ, USA; University of Arizona, Tucson, AZ, USA.

Coccidioidomycosis (CM), caused by the dimorphic fungi Coccidioides immitis (C. immitis) and C. posadasii, is recognized as an increasing threat both nationally and worldwide.

View Article and Find Full Text PDF
Article Synopsis
  • Coccidioidomycosis is a serious fungal infection that can be transmitted through organ transplantation, with a review of cases from 2013 to 2022 revealing significant risks.
  • Seven deceased donors transmitted the infection to eight recipients, resulting in a 40% infection rate among organ recipients.
  • The study highlights the importance of thorough donor evaluations and antifungal treatment to reduce the high mortality associated with these infections post-transplant.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!